As described here and in our previous report, cells with constitutively active c-Met respond to c-Met inhibition; however, monotherapy does not completely eradicate tumor growth, indicating that a bypass tumor survival mechanism is likely involved in the maintenance of tumor growth in the presence of c-Met pathway suppression [21]. This evidence concerns the gene MET and neoplasm.